Thrivent Financial for Lutherans
DTIL icon

Thrivent Financial for Lutherans’s Precision BioSciences DTIL Stock Holding History

Thrivent Financial for Lutherans’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-497
Closed -$92K – 2475
2020
Q3 		$92K Sell
497
-1,070
-68% -$213K ﹤0.01% 2346
2020
Q2 		$391K Hold
1,567
– – ﹤0.01% 2013
2020
Q1 		$284K Buy
+1,567
New +$410K ﹤0.01% 1997

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrivent Financial for Lutherans's DTIL Position: Q4 2020 in Review

Thrivent Financial for Lutherans sold out of Precision BioSciences (DTIL) in Q4 2020, closing a stake of 497 shares — an estimated $92K sold.

Thrivent Financial for Lutherans first reported a position in DTIL in Q1 2020 and held it in 3 quarters. The position peaked at $391K in Q2 2020. 118 funds tracked by Wall St. Rank hold DTIL as of Q4 2020.

  • Thrivent Financial for Lutherans reported no remaining Precision BioSciences position as of Q4 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 497 Precision BioSciences shares in Q4 2020, an estimated $92K.
  • Thrivent Financial for Lutherans first reported a position in Precision BioSciences in Q1 2020 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Precision BioSciences position peaked at $391K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2020, filed 16 Feb 2021.